Ironwood Pharmaceuticals | IRWD - Loan Capital

Stock Price
4.57
Daily Change
0.12 2.70%
Monthly
12.01%
Yearly
168.82%
Q1 Forecast
4.74

Ironwood Pharmaceuticals reported $583.99M in Loan Capital for its fiscal quarter ending in December of 2024.





Loan Capital Change Date
Acadia Pharmaceuticals USD 0 0 Mar/2025
Agios Pharmaceuticals USD 1.06M 0 Sep/2022
Almirall EUR 386.13M 4.5M Jun/2025
Alnylam Pharmaceuticals USD 1.04B 13.75M Sep/2025
Ardelyx USD 202.14M 27.07M Sep/2025
Astellas Pharma JPY 320B 0 Dec/2025
AstraZeneca USD 6.55B 19.43B Sep/2025
Charles River Laboratories USD 2.19B 146.92M Sep/2025
Exact Sciences USD 2.33B 9.34M Sep/2025
Halozyme Therapeutics USD 800.07M 709.03M Sep/2025
Incyte USD 35.37M 3.61M Sep/2025
Ironwood Pharmaceuticals USD 583.99M 14.83M Dec/2024
MacroGenics USD 70.26M 4K Sep/2025
Moderna USD 26M 6M Sep/2025
Myriad Genetics USD 119.5M 60.2M Sep/2025
Pacira USD 376.72M 1.37M Sep/2025
PTC Therapeutics USD 1.84B 298.68M Sep/2025
Sarepta Therapeutics USD 1.04B 104.31M Sep/2025
Takeda JPY 4.27T 81.29B Dec/2025
Ultragenyx Pharmaceutical USD 782.75M 11.3M Jun/2025